Literature DB >> 11517183

Ovarian granulosa cell tumors express a functional membrane receptor for anti-Müllerian hormone in transgenic mice.

M Dutertre1, L Gouédard, F Xavier, W Q Long, N di Clemente, J Y Picard, R Rey.   

Abstract

Anti-Müllerian hormone inhibits granulosa cell growth and function. Both anti-Müllerian hormone and its type II receptor are expressed in normal granulosa cells. We show by histologic and molecular analyses that ovarian tumors developing in transgenic mice, obtained by targeted oncogenesis using an anti-Müllerian hormone promoter-SV40 oncogene construct, are of granulosa-cell origin. Because tissue-specific, cell-surface molecules are of particular interest for the analysis and treatment of tumors, we examined the expression of anti-Müllerian hormone type II receptor in the ovaries of these transgenic mice. We demonstrate that the anti-Müllerian hormone type II receptor is expressed not only in normal ovarian follicles, but also in granulosa cell tumors. Using a cell line derived from one of these tumors, we show that the anti-Müllerian hormone type II receptor protein is present on the surface of tumor cells and binds anti-Müllerian hormone. Furthermore, we show that the anti-Müllerian hormone receptor is functional in the granulosa tumor cell line, with anti-Müllerian hormone treatment inducing selective activation of Smad1. In conclusion, in this study we present a new murine transgenic model of granulosa cell tumors of the ovary and, using this model, we demonstrate for the first time cell-surface expression of a highly tissue-specific molecule, anti-Müllerian hormone type II receptor, as well as the selective activation of Smad proteins by anti-Müllerian hormone, in granulosa tumor cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11517183     DOI: 10.1210/endo.142.9.8393

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  18 in total

1.  Autoimmune mediated regulation of ovarian tumor growth.

Authors:  Cengiz Z Altuntas; Ritika Jaini; Pavani Kesaraju; Daniel Jane-wit; Justin M Johnson; Kelly Covey; Christopher A Flask; Martin Dutertre; Jean-Yves Picard; Vincent K Tuohy
Journal:  Gynecol Oncol       Date:  2011-10-18       Impact factor: 5.482

Review 2.  Müllerian inhibiting substance/anti-Müllerian hormone: a potential therapeutic agent for human ovarian and other cancers.

Authors:  David T MacLaughlin; Patricia K Donahoe
Journal:  Future Oncol       Date:  2010-03       Impact factor: 3.404

3.  High-throughput Exploration of the Network Dependent on AKT1 in Mouse Ovarian Granulosa Cells.

Authors:  Maëva Elzaiat; Laetitia Herman; Bérangère Legois; Thibaut Léger; Anne-Laure Todeschini; Reiner A Veitia
Journal:  Mol Cell Proteomics       Date:  2019-04-16       Impact factor: 5.911

4.  Xenograft and Transgenic Mouse Models of Epithelial Ovarian Cancer and Non Invasive Imaging Modalities to Monitor Ovarian Tumor Growth In situ -Applications in Evaluating Novel Therapeutic Agents.

Authors:  Denise C Connolly; Harvey H Hensley
Journal:  Curr Protoc Pharmacol       Date:  2009-06-01

5.  Development of a syngeneic mouse model of epithelial ovarian cancer.

Authors:  Bridget A Quinn; Fang Xiao; Laura Bickel; Lainie Martin; Xiang Hua; Andres Klein-Szanto; Denise C Connolly
Journal:  J Ovarian Res       Date:  2010-10-19       Impact factor: 4.234

6.  The anti-Müllerian hormone type II receptor: insights into the binding domains recognized by a monoclonal antibody and the natural ligand.

Authors:  Imed Salhi; Sylvie Cambon-Roques; Isabelle Lamarre; Daniel Laune; Franck Molina; Martine Pugnière; Didier Pourquier; Marian Gutowski; Jean-Yves Picard; Françoise Xavier; André Pèlegrin; Isabelle Navarro-Teulon
Journal:  Biochem J       Date:  2004-05-01       Impact factor: 3.857

7.  Smad1-Smad5 ovarian conditional knockout mice develop a disease profile similar to the juvenile form of human granulosa cell tumors.

Authors:  Brooke S Middlebrook; Karen Eldin; Xiaohui Li; Sujatha Shivasankaran; Stephanie A Pangas
Journal:  Endocrinology       Date:  2009-10-09       Impact factor: 4.736

8.  Vitamin D alters genes involved in follicular development and steroidogenesis in human cumulus granulosa cells.

Authors:  Zaher Merhi; Angela Doswell; Kendall Krebs; Marilyn Cipolla
Journal:  J Clin Endocrinol Metab       Date:  2014-03-14       Impact factor: 5.958

9.  Aberrant granulosa cell-fate related to inactivated p53/Rb signaling contributes to granulosa cell tumors and to FOXL2 downregulation in the mouse ovary.

Authors:  Victoria Cluzet; Marie M Devillers; Florence Petit; Stéphanie Chauvin; Charlotte M François; Frank Giton; Catherine Genestie; Nathalie di Clemente; Joëlle Cohen-Tannoudji; Céline J Guigon
Journal:  Oncogene       Date:  2019-11-19       Impact factor: 9.867

10.  Technical challenges and limitations of current mouse models of ovarian cancer.

Authors:  Kenneth Garson; Lisa F Gamwell; Elizabeth Mg Pitre; Barbara C Vanderhyden
Journal:  J Ovarian Res       Date:  2012-11-29       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.